CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction.
<h4>Background</h4>The linkages between neuroinflammation and Alzheimer's disease (AD) pathogenesis are well established. What is not, however, is how specific immune pathways and proteins affect the disease. To this end, we previously demonstrated that transgenic over-expression of...
Saved in:
| Main Authors: | Tomomi Kiyota, Masaru Yamamoto, Huangui Xiong, Mary P Lambert, William L Klein, Howard E Gendelman, Richard M Ransohoff, Tsuneya Ikezu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2009-07-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0006197&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
by: Nicholas J Izzo, et al.
Published: (2014-01-01) -
Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.
by: Kiyotaka Tokuraku, et al.
Published: (2009-12-01) -
The role of microglia in neurocognitive deficits induced by general anaesthetic agents during neurodevelopment
by: Xinyue Liang, et al.
Published: (2024-12-01) -
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.
by: Leila M Luheshi, et al.
Published: (2010-03-01) -
Unique N-glycosylation signatures in human iPSC derived microglia activated by Aβ oligomer and lipopolysaccharide
by: Xinyu Tang, et al.
Published: (2025-04-01)